#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Clifford Stocks Email
CEO . OncoResponse
How to contact Clifford Stocks
Join and see Clifford's contact info for free!Current Roles
Employees:
16Revenue:
$0About
OncoResponse is a clinical stage, privately held immuno-oncology biotech company developing cancer immunotherapies using clues from the immune systems of elite cancer responders. In a broad strategic alliance with MD Anderson Cancer Center, OncoResponse deploys a proprietary B-cell discovery platform to identify and develop novel therapeutics targeting the tumor microenvironment. The company’s lead candidate, OR2805, has entered clinical studies with a unique and transformative approach to the advancement of cancer therapeutics. \n\nOncoResponse is based in Seattle, Washington.OncoResponse Address
1124 Columbia StreetSeattle, WA
United States